New hope for liver cancer: Triple-Drug combo under study
Disease control
Ongoing
This study tests a new combination of three drugs (casdozokitug, toripalimab, and bevacizumab) in 72 people with advanced liver cancer that cannot be removed by surgery. The main goals are to see if the combination is safe and shrinks tumors. Participants must have measurable tum…
Phase: PHASE2 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated May 17, 2026 03:54 UTC